Should 13-Valent Protein-Conjugate Pneumococcal Vaccine Be Used Routinely in Adults?

被引：32
|
作者：
Musher, Daniel M. [1 ,2 ,3 ]
机构：
[1] Michael E DeBakey VA Med Ctr, Med Care Line Infect Dis Sect, Houston, TX USA
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2012年 / 55卷 / 02期
关键词：
POLYSACCHARIDE VACCINE; COST-EFFECTIVENESS; HIV-INFECTION; EFFICACY; TRIAL; PNEUMONIA; BLIND;
D O I：
10.1093/cid/cis364
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：265 / 267
页数：3
相关论文
共 50 条
  • [1] Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
    Gladstone, Rebecca A.
    Jefferies, Johanna M.
    Faust, Saul N.
    Clarke, Stuart C.
    EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 889 - 902
  • [2] Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) In Older Adults
    Sanford, Mark
    DRUGS, 2012, 72 (09) : 1243 - 1255
  • [3] 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Plosker, Greg L.
    DRUGS, 2015, 75 (13) : 1535 - 1546
  • [4] Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years
    Weycker, Derek
    Sato, Reiko
    Strutton, David
    Edelsberg, John
    Atwood, Mark
    Jackson, Lisa A.
    VACCINE, 2012, 30 (36) : 5437 - 5444
  • [5] Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
    Ordonez, Jaime E.
    Orozco, John J.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [6] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
    Jackson, Lisa A.
    Gurtman, Alejandra
    van Cleeff, Martin
    Jansen, Kathrin U.
    Jayawardene, Deepthi
    Devlin, Carmel
    Scott, Daniel A.
    Emini, Emilio A.
    Gruber, William C.
    Schmoele-Thoma, Beate
    VACCINE, 2013, 31 (35) : 3577 - 3584
  • [7] Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine
    Miller, Elizabeth
    Andrews, Nicholas J.
    Waight, Pauline A.
    Slack, Mary P. E.
    George, Robert C.
    VACCINE, 2011, 29 (49) : 9127 - 9131
  • [8] Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Adults in the Philippines
    Santiaguel, Joel
    Averin, Ahuva
    Nua, Winniefer
    Atwood, Mark
    Huang, Liping
    Hariharan, Dhwani
    Guerrero, Josephine
    Zotomayor, Ricardo
    David-Wang, Aileen
    VALUE IN HEALTH REGIONAL ISSUES, 2025, 47
  • [9] Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
    Esposito, Susanna
    Principi, Nicola
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [10] Pneumococcal Conjugate Vaccine-elicited Antibody Persistence and Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Children Previously Vaccinated with 4 Doses of Either 7-Valent or 13-Valent Pneumococcal Conjugate Vaccine
    Quinet, Beatrice
    Laudat, France
    Gurtman, Alejandra
    Patterson, Scott
    Sidhu, Mohinder
    Gruber, William C.
    Scott, Daniel A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (10) : 1065 - 1076
12345